Home Healthcare Market: Growth, Size, Share, and Trends

Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region - Global Forecast to 2028

Report Code: MD 1160 Jan, 2024, by marketsandmarkets.com

Market Growth Outlook Summary

The global home healthcare market is projected to grow significantly, expanding from USD 250 billion in 2023 to USD 383 billion by 2028, at a robust CAGR of 8.9%. The key drivers of this growth include the increasing elderly population, a rise in chronic conditions, the demand for cost-effective healthcare solutions, and advancements in home healthcare technology. However, challenges such as evolving reimbursement policies, limited insurance coverage, and concerns over patient safety may moderate growth to some extent.

Home Healthcare Market Size, Dynamics & Ecosystem

Home Healthcare Market Size, Dynamics & Ecosystem

To know more about the assumptions used for this study, Request for Free Sample Report

Home Healthcare Market Dynamics

Driver: Increasing Elderly Population & Prevalence of Chronic Illnesses

According to the UN Department of Economic and Social Affairs, the global population over 65 is projected to grow from 771 million in 2022 to 1.6 billion by 2050. The number of people aged 80 and older will triple by 2050, significantly driving demand for healthcare services. With the elderly population more prone to chronic conditions, this demographic shift will boost demand for home healthcare services. Home healthcare provides a cost-effective solution by reducing hospital stays, readmissions, and travel time for appointments.

Opportunity: Expanding Role of Telehealth

Telehealth has become a critical component in home healthcare, offering continuous patient monitoring and early intervention through remote consultations. Telehealth services encompass virtual medical consultations, health management, and remote patient monitoring. These advancements provide patients with easier access to healthcare, improving outcomes and reducing the need for in-person visits. The growing use of telehealth is expected to enhance the efficiency and reach of home healthcare services.

Restraint: Limited Insurance Coverage

While many North American countries offer insurance coverage for home healthcare services, there are significant limitations, particularly for advanced equipment like multi-parameter monitors and telemetry. In regions like Europe and Asia, insurance coverage varies widely, with some countries only reimbursing post-hospital care rather than ongoing in-home healthcare, limiting the market's full potential.

Challenge: Shortage of Skilled Homecare Workers

There is an acute shortage of homecare professionals, a significant challenge in meeting the growing demand for home healthcare services. Projections from the US Bureau of Labor Statistics suggest a need for 924,000 new personal care aides and home health aides by 2031. This gap could restrict the market's growth unless workforce shortages are addressed, highlighting the need for innovative staffing solutions and workforce training in homecare services.

The home healthcare market is moderately consolidated, with major players such as Fresenius SE & Co. KGaA (Germany), Abbott (US), GE Healthcare (US), Koninklijke Philips NV (Netherlands), ResMed Inc. (US), Linde Plc (Ireland), and F. Hoffmann-La Roche Ltd. (Switzerland) holding a significant market share in 2022. These companies benefit from large-scale operations, substantial R&D investments, and established distribution networks, which present a barrier to new entrants in the market.

Home Healthcare Market Segmentation & Geographical Spread

Home Healthcare Market Segmentation & Geographical Spread

For detailed assumptions in this study, download the PDF brochure

Therapeutic Products Lead the Home Healthcare Market

The home healthcare market is categorized into mobility care, therapeutic products, and testing & monitoring devices. In 2022, therapeutic products accounted for the largest share, driven by rising demand for equipment related to chronic conditions like respiratory diseases and kidney failure.

Skilled Nursing Services Hold the Largest Market Share by Service

Skilled nursing services, which include rehabilitation, hospice care, and respiratory therapies, dominate the home healthcare service sector. Patients prefer receiving care at home over institutional settings, driving the growth of skilled nursing services. This segment's market expansion is also supported by comprehensive insurance coverage.

Other Indications Drive Home Healthcare Growth

The home healthcare market is segmented by indications such as wound care, diabetes, cardiovascular diseases, and respiratory disorders. In 2022, the "Other Indications" category led the market, fueled by the increasing prevalence of HIV and sleep disorders, which require ongoing homecare management.

North America Leads the Global Home Healthcare Market

North America dominated the global home healthcare market in 2022, owing to a high incidence of chronic diseases and escalating healthcare costs. However, the Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by an aging population and technological innovations in home healthcare.

The leading players in the home healthcare market include Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Philips NV. (Netherlands), and ResMed Inc. (US). These companies maintain leadership through comprehensive product portfolios, substantial R&D investments, and expansive distribution networks.

Home Healthcare Market Report Scope

Report Metric

Details

Market Revenue Size in 2023

$250.0 Billion

Projected Revenue Size by 2028

$383.0 Billion

Industry Growth Rate

Poised to Grow at a CAGR of 8.9%

Market Driver

Sharp increase in the number of older people and the prevalence of chronic illnesses

Market Opportunity

Growing focus on newer technologies such as telehealth

This report categorizes the home healthcare market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Therapeutic Products
  • Testing, Screening, and Monitoring Products
  • Mobility Care Products

By Service

  • Skilled Nursing
  • Rehabilitation Therapy
  • Hospice & Palliative Care
  • Unskilled Care
  • Respiratory Therapy
  • Infusion Therapy
  • Pregnancy Care

By Indication

  • Cancer
  • Respiratory Diseases
  • Movement Disorders
  • Cardiovascular Diseases & Hypertension
  • Pregnancy
  • Wound Care
  • Diabetes
  • Hearing Disorders
  • Other Indications

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World
    • Latin America
    • Middle East Africa

Recent Developments in the Home Healthcare Market

  • In August 2022, Fresenius Medical Care North America (FMCNA) acquired InterWell Health Brand (US) to strengthen expertise in kidney care value-based contracting and performance.
  • In August 2022, Contessa (US) partnered with Mount Sinai Health System (US) to offer a comprehensive range of home-based care services, including hospitalization at home and palliative care at home.
  • In July 2022, Invacre Corporation (US) introduced the Next Generation e-fix eco Power Assist Device designed to transform manual wheelchairs, enhancing mobility and independence for patients.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

INTRODUCTION
26
RESEARCH METHODOLOGY
31
EXECUTIVE SUMMARY
44
PREMIUM INSIGHTS
48
MARKET OVERVIEW
52
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rapid growth in elderly population and rising incidence of chronic diseases
    - Rising R&D investments
    - Need for cost-effective healthcare delivery due to rising costs
    - Increased preference for personalized care
    RESTRAINTS
    - Changing reimbursement policies
    - Limited insurance coverage
    - Patient safety concerns
    OPPORTUNITIES
    - Rising focus on telehealth
    - Untapped developing regions
    - Growing demand for home-use therapeutic devices
    - Growing demand for home sleep apnea tests
    - Rising preference for home hemodialysis treatment
    CHALLENGES
    - Shortage of home care workers
    - Lack of supporting infrastructure
  • 5.3 PRICING ANALYSIS
    PRICING MODEL ANALYSIS
  • 5.4 PATENT ANALYSIS
    LIST OF KEY PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM/MARKET MAP
    HOME HEALTHCARE MARKET: ROLE IN ECOSYSTEM
  • 5.8 PORTER’S FIVE FORCES ANALYSIS
    PULSE OXIMETERS
    - Threat of new entrants
    - Threat of substitutes
    - Bargaining power of suppliers
    - Bargaining power of buyers
    - Degree of competition
    HEARING AIDS
    - Threat of new entrants
    - Threat of substitutes
    - Bargaining power of buyers
    - Bargaining power of suppliers
    - Degree of competition
  • 5.9 PESTLE ANALYSIS
  • 5.10 REGULATORY LANDSCAPE
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - China
    - India
  • 5.11 TRADE ANALYSIS
    TRADE ANALYSIS FOR BLOOD PRESSURE MONITORS
  • 5.12 TECHNOLOGY ANALYSIS
  • 5.13 KEY CONFERENCES & EVENTS IN 2023–2024
  • 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.15 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.16 CASE STUDY ANALYSIS
    CASE STUDY: FUTURE OF HOME HEALTH PROJECT
HOME HEALTHCARE MARKET, BY PRODUCT
91
  • 6.1 INTRODUCTION
  • 6.2 THERAPEUTIC PRODUCTS
    DIALYSIS EQUIPMENT
    - Dialysis equipment to hold largest market share
    WOUND CARE PRODUCTS
    - Decreased costs and higher convenience and comfort to drive market
    IV EQUIPMENT
    - Accuracy and growing target disease prevalence to ensure market growth
    SLEEP APNEA THERAPEUTIC DEVICES
    - Increasing patient preference for home-based sleep tests to fuel market
    INSULIN DELIVERY DEVICES
    - High incidence of diabetes to drive market
    OXYGEN DELIVERY SYSTEMS
    - Technological advancements in oxygen therapy products to drive market
    INHALERS
    - High incidence of asthma to boost market
    NEBULIZERS
    - Effectiveness over oral dosages to push preference for nebulizers
    VENTILATORS
    - Convenience and comfort to sustain end-user preference
    OTHER THERAPEUTIC PRODUCTS
  • 6.3 TESTING, SCREENING, AND MONITORING PRODUCTS
    BLOOD GLUCOSE MONITORS
    - Increasing prevalence of diabetes to drive market growth
    HEARING AIDS
    - High incidence of hearing impairment to drive market
    ACTIVITY MONITORS & WRISTBANDS
    - Increasing prevalence of chronic diseases to bolster demand for activity monitors
    ECG/EKG DEVICES
    - High prevalence of CVD to support demand
    TEMPERATURE MONITORING DEVICES
    - Technological innovations and increasing awareness to drive growth
    HEART RATE MONITORS
    - Continuous cardiac parameter monitoring capabilities to drive demand
    PULSE OXIMETERS
    - Rising disease incidence and wide usage of pulse oximetry to ensure strong demand
    OVULATION & PREGNANCY TEST KITS
    - Privacy, convenience, accessibility, and quick results to drive market
    BLOOD PRESSURE MONITORS
    - Rising patient population for hypertension and CVD to drive market
    HIV TEST KITS
    - Rising prevalence of HIV to drive market
    FETAL MONITORING DEVICES
    - Remote-based care by portable fetal monitoring systems to drive market growth
    HOLTER & EVENT MONITORS
    - Rising awareness of preventive care and technological advancements to drive market
    DRUG & ALCOHOL TEST KITS
    - Rising consumption of drugs among teens to support market growth
    COAGULATION MONITORING PRODUCTS
    - Rising use of anticoagulant therapy and availability of home-use kits to drive market
    PEAK FLOW METERS
    - High portability and cost-efficiency to ensure adoption
    COLON CANCER TEST KITS
    - High incidence of colorectal cancer to drive market growth
    EEG DEVICES
    - Wide patient population for epilepsy to drive market for EEG devices
    HOME SLEEP TESTING DEVICES
    - Cost-effectiveness of home-based sleep tests to fuel growth
    CHOLESTEROL TESTING PRODUCTS
    - Rising obesity levels and CVD incidence to support market
    HOME HBA1C TEST KITS
    - High incidence of diabetes to drive market
  • 6.4 MOBILITY CARE PRODUCTS
    WHEELCHAIRS
    - Increased preference for wheelchairs to boost demand
    MOBILITY SCOOTERS
    - High cost to affect end-user adoption
    WALKERS & ROLLATORS
    - Difficulties in using walkers and availability of alternatives to restrain market
    CRUTCHES
    - High preference for axilla crutches to support demand
    CANES
    - Wide usage of canes to drive market
HOME HEALTHCARE MARKET, BY SERVICE
129
  • 7.1 INTRODUCTION
  • 7.2 SKILLED NURSING SERVICES
    SKILLED NURSING SERVICES TO DOMINATE MARKET
  • 7.3 REHABILITATION THERAPY SERVICES
    RISING DEMAND, GROWING GERIATRIC POPULATION, AND INCREASING DISEASE INCIDENCE TO BOOST DEMAND
  • 7.4 HOSPICE & PALLIATIVE CARE SERVICES
    RISING GERIATRIC POPULATION TO DRIVE DEMAND
  • 7.5 UNSKILLED CARE SERVICES
    COST-EFFECTIVENESS TO DRIVE GROWTH
  • 7.6 RESPIRATORY THERAPY SERVICES
    GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET
  • 7.7 INFUSION THERAPY SERVICES
    SAFETY AND EFFECTIVENESS OF HOME INFUSION TO DRIVE DEMAND
  • 7.8 PREGNANCY CARE SERVICES
    NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE MARKET GROWTH
HOME HEALTHCARE MARKET, BY INDICATION
139
  • 8.1 INTRODUCTION
  • 8.2 CANCER
    CANCER TO DOMINATE INDICATIONS MARKET
  • 8.3 RESPIRATORY DISEASES
    RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET
  • 8.4 MOVEMENT DISORDERS
    GROWING GERIATRIC POPULATION TO DRIVE DEMAND FOR THERAPY EQUIPMENT
  • 8.5 PREGNANCY
    RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH
  • 8.6 CVD & HYPERTENSION
    RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE GROWTH
  • 8.7 WOUND CARE
    GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET
  • 8.8 DIABETES
    INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH
  • 8.9 HEARING DISORDERS
    WORLDWIDE INCREASE IN HEARING DISABILITIES TO ENSURE SUSTAINED GROWTH
  • 8.10 OTHER INDICATIONS
HOME HEALTHCARE MARKET, BY REGION
150
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to dominate North American home healthcare market
    CANADA
    - Rising geriatric population to drive market
  • 9.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Germany to retain market leadership in Europe
    UK
    - Rising burden of chronic diseases to boost market growth
    FRANCE
    - Government support and initiatives taken by market players to boost market
    ITALY
    - Rising geriatric population and favorable government policy to drive market
    SPAIN
    - Rising geriatric population and incidence of chronic conditions to drive market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    JAPAN
    - Japan to command largest share of APAC market
    CHINA
    - Healthcare development and reforms to drive market growth
    INDIA
    - Increasing target patient population to drive market
    REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD
    REST OF THE WORLD: RECESSION IMPACT
    LATIN AMERICA
    - Aging population to favor market growth
    MIDDLE EAST & AFRICA
    - GCC Countries
    - Rest of the Middle East & Africa
COMPETITIVE LANDSCAPE
255
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT
  • 10.6 START-UP/SME EVALUATION MATRIX
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING
  • 10.7 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
268
  • 11.1 KEY PLAYERS
    FRESENIUS SE & CO. KGAA
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    LINDE PLC
    - Business overview
    - Products/Solutions/Services offered
    - MnM view
    F. HOFFMANN-LA ROCHE
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    RESMED
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    KONINKLIJKE PHILIPS
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    GE HEALTHCARE
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    A&D COMPANY
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    INVACARE CORPORATION
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    AMEDISYS
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    LHC GROUP
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    OMRON CORPORATION
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    BAYADA HOME HEALTH CARE
    DRIVE DEVILBISS HEALTHCARE LIMITED
    SUNRISE MEDICAL
    ROMA MEDICAL
    CAREMAX REHABILITATION EQUIPMENT
    VITALOGRAPH
    ADVITA PFLEGEDIENST
    RENAFAN GMBH
    CONTEC MEDICAL SYSTEMS
    B. BRAUN MELSUNGEN AG
    BAXTER INTERNATIONAL
    MEDLINE INDUSTRIES
    ADVIN HEALTH CARE
APPENDIX
333
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • TABLE 2 KEY DATA FROM PRIMARY SOURCES
  • TABLE 3 GERIATRIC POPULATION, 2022 VS. 2050 (MILLION)
  • TABLE 4 PRODUCT LAUNCHES
  • TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (2023)
  • TABLE 6 AVERAGE SELLING PRICE OF HOME HEALTHCARE PRODUCTS, BY REGION (2023)
  • TABLE 7 PULSE OXIMETERS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 8 HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 US FDA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 17 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
  • TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 19 IMPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION)
  • TABLE 20 EXPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION)
  • TABLE 21 HOME HEALTHCARE MARKET: KEY CONFERENCES & EVENTS, 2023–2024
  • TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
  • TABLE 23 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
  • TABLE 24 HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 25 KEY THERAPEUTIC PRODUCTS OFFERED
  • TABLE 26 THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 27 THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 28 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 31 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 32 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 33 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 34 INHALERS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 35 NEBULIZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 36 VENTILATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 37 OTHER THERAPEUTIC PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 38 KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED
  • TABLE 39 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 40 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 41 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 42 HEARING AIDS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 43 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 44 ECG/EKG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 45 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 46 HEART RATE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 47 PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 48 OVULATION & PREGNANCY TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 49 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 50 HIV TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 51 FETAL MONITORING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 52 HOLTER & EVENT MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 53 DRUG & ALCOHOL TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 54 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 55 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 56 COLON CANCER TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 57 EEG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 58 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 59 CHOLESTEROL TESTING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 60 HOME HBA1C TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 61 KEY MOBILITY CARE PRODUCTS AVAILABLE IN THE MARKET
  • TABLE 62 MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 63 MOBILITY CARE PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 64 WHEELCHAIRS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 65 MOBILITY SCOOTERS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 66 WALKERS & ROLLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 67 CRUTCHES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 68 CANES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 69 US: AVERAGE SENIOR CARE COST, BY TYPE, 2022
  • TABLE 70 HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 71 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 72 SKILLED NURSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 73 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 74 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 75 UNSKILLED SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 76 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 77 INFUSION THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 78 PREGNANCY CARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 79 HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 80 HOME HEALTHCARE INDICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 81 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
  • TABLE 82 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 83 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 84 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 85 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 86 HOME HEALTHCARE MARKET FOR CVD & HYPERTENSION, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 87 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 88 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 89 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 90 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 91 HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 92 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 93 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 94 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 95 NORTH AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 96 NORTH AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 97 NORTH AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 98 NORTH AMERICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 99 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 100 US: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 101 US: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 102 US: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 103 US: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 104 US: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 105 US: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 106 US: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 107 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 108 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 109 CANADA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 110 CANADA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 111 CANADA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 112 CANADA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 113 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 114 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 115 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 116 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 117 EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 118 EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 119 EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 120 EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 121 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 122 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 123 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 124 GERMANY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 125 GERMANY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 126 GERMANY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 127 GERMANY: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 128 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 129 UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 130 UK: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 131 UK: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 132 UK: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 133 UK: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 134 UK: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 135 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 136 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 137 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 138 FRANCE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 139 FRANCE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 140 FRANCE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 141 FRANCE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 142 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 143 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 144 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 145 ITALY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 146 ITALY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 147 ITALY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 148 ITALY: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 149 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 150 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 151 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 152 SPAIN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 153 SPAIN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 154 SPAIN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 155 SPAIN: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 156 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 157 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 158 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 159 REST OF EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 160 REST OF EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 161 REST OF EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 162 REST OF EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 163 REST OF EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 164 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 172 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 173 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 174 JAPAN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 175 JAPAN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 176 JAPAN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 177 JAPAN: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 178 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 179 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 180 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 181 CHINA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 182 CHINA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 183 CHINA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 184 CHINA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 185 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 186 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 187 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 188 INDIA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 189 INDIA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 190 INDIA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 191 INDIA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 192 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 193 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 200 ROW: HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 201 ROW: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 202 ROW: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 203 ROW: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 204 ROW: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 205 ROW: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 206 ROW: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 207 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 208 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 209 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 210 LATIN AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 211 LATIN AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 212 LATIN AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 213 LATIN AMERICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 214 LATIN AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 215 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION)
  • TABLE 216 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 217 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 218 MIDDLE EAST & AFRICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 219 MIDDLE EAST & AFRICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 220 MIDDLE EAST & AFRICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 221 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 222 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 223 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 224 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 225 GCC COUNTRIES: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 226 GCC COUNTRIES: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 228 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 230 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
  • TABLE 231 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
  • TABLE 232 ROMEA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 233 ROMEA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 234 ROMEA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
  • TABLE 235 ROMEA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
  • TABLE 236 ROMEA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
  • TABLE 237 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HOME HEALTHCARE PRODUCT MANUFACTURERS
  • TABLE 238 HOME HEALTHCARE MARKET: DEGREE OF COMPETITION
  • TABLE 239 PRODUCT FOOTPRINT (FIVE PLAYERS)
  • TABLE 240 REGIONAL FOOTPRINT (FIVE PLAYERS)
  • TABLE 241 COMPETITIVE BENCHMARKING OF KEY PLAYERS
  • TABLE 242 HOME HEALTHCARE MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • TABLE 243 COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • TABLE 244 HOME HEALTHCARE MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 245 HOME HEALTHCARE MARKET: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 246 HOME HEALTHCARE MARKET: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
  • TABLE 247 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW
  • TABLE 248 FRESENIUS SE & CO. KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 249 FRESENIUS SE & CO. KGAA: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 250 FRESENIUS SE & CO. KGAA: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 251 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
  • TABLE 252 ABBOTT: COMPANY OVERVIEW
  • TABLE 253 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 254 ABBOTT: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 255 ABBOTT: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 256 LINDE: COMPANY OVERVIEW
  • TABLE 257 LINDE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 258 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
  • TABLE 259 F. HOFFMAN-LA ROCHE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 260 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 261 F. HOFFMANN-LA ROCHE: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 262 RESMED: COMPANY OVERVIEW
  • TABLE 263 RESMED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 264 RESMED: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 265 RESMED: DEALS
  • TABLE 266 KONINKLIJKE PHILIPS: COMPANY OVERVIEW
  • TABLE 267 KONINKLIJKE PHILIPS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 268 KONINKLIJKE PHILIPS: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 269 KONINKLIJKE PHILIPS: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 270 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 271 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 272 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 273 A&D COMPANY: COMPANY OVERVIEW
  • TABLE 274 A&D COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 275 A&D COMPANY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 276 INVACARE CORPORATION: COMPANY OVERVIEW
  • TABLE 277 INVACARE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 278 INVACARE CORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
  • TABLE 279 AMEDISYS: COMPANY OVERVIEW
  • TABLE 280 AMEDISYS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 281 AMEDISYS: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 282 LHC GROUP: COMPANY OVERVIEW
  • TABLE 283 LHC GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 284 LHC GROUP: DEALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 285 OMRON CORPORATION: COMPANY OVERVIEW
  • TABLE 286 OMRON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 287 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
  • TABLE 288 OMRON CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)
LIST OF FIGURES
 
  • FIGURE 1 HOME HEALTHCARE MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HOME HEALTHCARE MARKET)
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 HOME HEALTHCARE MARKET: TOP-DOWN APPROACH
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
  • FIGURE 8 HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD BILLION)
  • FIGURE 9 HOME HEALTHCARE MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION)
  • FIGURE 10 HOME HEALTHCARE MARKET, BY SERVICE, 2023 VS. 2028 (USD BILLION)
  • FIGURE 11 HOME HEALTHCARE MARKET, BY INDICATION, 2023 VS. 2028 (USD BILLION)
  • FIGURE 12 HOME HEALTHCARE MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 13 RISING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH
  • FIGURE 14 JAPAN AND CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 15 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 16 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 17 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18 PATENT ANALYSIS FOR TEMPERATURE MONITORING DEVICES (JANUARY 2013–DECEMBER 2022)
  • FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • FIGURE 20 HOME HEALTHCARE MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 21 HOME HEALTHCARE MARKET: ECOSYSTEM/MARKET MAP
  • FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
  • FIGURE 23 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA
  • FIGURE 24 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES
  • FIGURE 25 REVENUE SHIFT IN HOME HEALTHCARE
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
  • FIGURE 27 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
  • FIGURE 28 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
  • FIGURE 29 APAC: HOME HEALTHCARE MARKET SNAPSHOT
  • FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS
  • FIGURE 31 HOME HEALTHCARE MARKET SHARE ANALYSIS (2022)
  • FIGURE 32 HOME HEALTHCARE MARKET: COMPANY EVALUATION MATRIX, 2022
  • FIGURE 33 COMPANY FOOTPRINT (FIVE COMPANIES)
  • FIGURE 34 HOME HEALTHCARE MARKET: START-UP/SME EVALUATION MATRIX, 2022
  • FIGURE 35 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2022)
  • FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2022)
  • FIGURE 37 LINDE: COMPANY SNAPSHOT (2022)
  • FIGURE 38 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
  • FIGURE 39 RESMED: COMPANY SNAPSHOT (2022)
  • FIGURE 40 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2022)
  • FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
  • FIGURE 42 A&D COMPANY: COMPANY SNAPSHOT (2022)
  • FIGURE 43 INVACARE CORPORATION: COMPANY SNAPSHOT (2022)
  • FIGURE 44 AMEDISYS: COMPANY SNAPSHOT (2022)
  • FIGURE 45 LHC GROUP: COMPANY SNAPSHOT (2022)
  • FIGURE 46 OMRON CORPORATION: COMPANY SNAPSHOT (2022)

The objective of the study is analyzing the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies’ developments such as acquisitions, product launches, expansions, agreements and partnerships of the leading players, the competitive landscape of the home healthcare market to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Home Healthcare Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

Abbott

Marketing Manager

Resmed

Senior Product Manager

GE Healthcare

Marketing Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the home healthcare market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the home healthcare market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Home healthcare Market Size: Bottom-Up Approach

Home Healthcare Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Home healthcare Market Size: Top-Down Approach

Home Healthcare Market Size, and Share

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Home healthcare refers to the medical attention, care and support provided to patients at residences by licensed healthcare workers, such as nurses, home health aides, and personal care aides. The home healthcare market includes products and services that can be set up remotely at patient’s home.

Key Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department

Report Objectives

  • To define, describe, segment, and forecast the global home healthcare market, by products, service, indication, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall home healthcare market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
  • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

Available Customizations

MarketsandMarkets offers the following customizations for this market report

Country Information

  • Additional country-level analysis of the home healthcare market

Company profiles

  • Additional five company profiles of players operating in the home healthcare market.

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the home healthcare market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
MD 1160
Published ON
Jan, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Home Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
knowledgestore logo

Want to explore hidden markets that can drive new revenue in Home Healthcare Market?

Find Hidden Markets
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
Website Feedback